Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
PaperCitations, authors & open-access status
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 93 citations, 2020 year and bronze oa status.
93
Citations
2020
Year
bronze
OA Status